Amylin’s Byetta Records $7.5 Mil. In Sales Following June Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
Market uptake for the product could be stronger than Rx tracking numbers show due to strength in mail-order prescriptions, the company said.